ArticleTherapeutic advances in gastroenterology2016

Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule.

Michael Kukulka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.